CANBERRA/SYDNEY – Australian Prime Minister Scott Morrison on Friday (Oct 1) announced an 18-month ban on Australians travelling abroad will be lifted from next month, easing one of the toughest Covid-19 restrictions imposed globally.
Reopening the international border for citizens and permanent residents will be linked to the establishment of home quarantine in Australia’s eight states and territories, Morrison said, meaning that some parts of the country will reopen sooner than others.
The first phase of the plan will focus on citizens and permanent residents being allowed to leave Australia, with further changes expected to permit foreign travellers to enter the country.
“It’s time to give Australians their lives back. We’ve saved lives,” Morrison said during a televised media conference. “We’ve saved livelihoods, but we must work together to ensure that Australians can reclaim the lives that they once had in this country.”
Morrison slammed the international border shut in March 2020. Since then, only a limited number of people have been granted a permit to leave the country for critical business or humanitarian reasons.
Citizens and permanent residents have been allowed to return from abroad, subject to quota limits and a mandatory 14-day quarantine period in a hotel at their own expense. There have also been a few high profile exceptions granted for entry for business purposes, including Hollywood actors to film movies and tv shows.
Morrison said he expects the first home quarantine systems to be up and running in November, but the timetable will be set by individual states and territories.
To support the reopening of borders and allow more Australians to return, officials expanded the country’s list of recognised Covid-19 vaccines.
The addition of China’s Sinovac vaccine in particular is expected to give Australia’s key international education sector a boost when foreign travellers are allowed to enter the country.
Chinese students, many of whom are likely to have received the Sinovac vaccine, account for a third of a sector that was worth A$35 billion (S$34.4 billion) a year to Australia’s A$2 trillion economy prior to the pandemic.
Covishield, a version of AstraZeneca’s vaccine produced by the Serum Institute of India, will also be added to the approved list, joining the three vaccines being administered in Australia — Pfizer , Moderna and AstraZeneca.
This article was first published in Asia One . All contents and images are copyright to their respective owners and sources.